The use of superdelayed thallium-201 single photon emission computed tomography (<SUP>201</SUP>Tl SPECT) for differentiating malignant gliomas from cerebral metastases was investigated in 23 patients (7 with me ningioma, 6 with glioma, 7 with cerebral metastasis, 1 with each of neurinoma, abscess, and necrosis). 4 mCi of <SUP>201</SUP>Tl was injected intravenously, and gamma camera scans were performed after 10 minutes and 4, 24, 72, and 96 hours (superdelayed scan). The mean thallium index of meningiomas was significantly higher than those of gliomas and cerebral metastases after 10 minutes, while the mean thallium indices of meningiomas and gl.iomas were significantly higher than those of cerebral metastases after 96 hours. The combination of early and superdelayed <SUP>201</SUP>Tl SPECT may be useful in differentiating malignant gliomas from cerebral metastases.
Introduction
Malignant gliomas are sometimes difficult to differen tiate from cerebral metastatic tumors on conven tional computed tomography (CT) scans. The ideal radiopharmaceutical for tumor localization should be readily available and have a high affinity for neoplastic tissue relative to normal tissue.",") Seven gamma emitting-labeled tumor screening agents have been used to visualize tumors.s'8'1o,", 9' The most promising agent for detecting brain tumors is thought to be thallium-201 (201T1).1,2,6,14,18.22) 201Tl, a potassium analogue, reflects the regional blood flow,3,'2) destruction of the blood-brain barrier, and Na+-K+ adenosine triphosphatase (ATPase) activi ty. 3,9,",13) 20'Tl is apparently incorporated into viable tumor cells more rapidly than into normal brain cells. 14,16) 20'T1 can differentiate tumors from infec tions, infarctions, and necrosis 2-4,1,15,16,21) low and high-grade gliomas,6,14,18,22) and identify residual as trocytomas after radiation therapy. 3,4,7,15,'6,2' Various radionuclide agents have been used to detect cerebral metastases, including technetium 99m") and 201T1.') However, the differentiation of cerebral metastases from gliomas by 201T1 single photon emission computed tomography (SPECT) has not been reported.
Here we describe a superdelayed 201T1 SPECT technique which can discriminate malignant gliomas from cerebral metastases.
Materials and Methods
We performed 201T1 SPECT, and CT or magnetic resonance (MR) imaging on 23 patients with brain tumors: seven patients with meningioma, six with malignant glioma, seven with cerebral metastasis, and three with neurinoma, abscess, and necrosis (1 each). All six gliomas were grade 3 or 4 according to the standard Kernohan and Sayre classification. 11,21) The seven metastatic lesions originated in the lung in six cases and breast in one. The seven meningiomas were five fibrous and two meningothelial types.
Each patient was injected with 120 MBq (4 mCi) of 201T1 in physiological saline solution. SPECT scans were made 10 minutes and 4, 24, 72, and 96 hours (superdelayed scan) after injection using a STARCAM 400ACT (General Electric CGR, Kriens, Switzerland). Images were acquired with 64 angular steps over 360° at 60 sec/step, with an average of 30,000 cps/step. Each slice was 4 mm in thickness. A 64 x 64 matrix with a Hanning lamp filter (Gen eral Electric CGR) was used to reconstruct images in the transverse plane.
Operator-defined regions of interest (ROI) were drawn around the tumor based on CT or MR im aging findings. These same regions were used for comparison with follow-up scans. The ROI for nonaffected tissue was determined by creating a mir ror image of the tumor ROI on the contralateral side."' The thallium index, to allow comparison be tween serial scans, was calculated as follows"):
Thallium index = (tumor region counts normal region counts) /normal region counts
The mean thallium indices of meningiomas, malig nant gliomas, and cerebral metastases were com pared with a one-tailed Student's t-test. The surgical specimen was a fibrous meningioma.
Results

201T1 SPECT
and CT or MR imaging studies demonstrated abnormalities of apparently the same size and location in the brain of all patients (Figs. 1  3) . Table 1 shows the mean thallium index of menin giomas, gliomas, cerebral metastases, and other le sions. The mean thallium index 10 minutes after in jection in meningiomas was significantly higher than that in gliomas (p < 0.05) and in cerebral metastases (p < 0.05). However, there was no significant difference in mean thallium index between gliomas and cerebral metastases. The mean thallium index of cerebral metastases at 96 hours after injection was significantly lower than those of meningiomas and gliomas (p < 0.05).
The washout rates (tumor region counts normal region counts at 96 hrs/tumor region counts nor mal region counts at 10 min) were 0.11 ± 0.04 (mean ± SE) in meningiomas, 0.19 ± 0.11 in gliomas, and 0.03 ± 0.06 in cerebral metastases. The washout rate in gliomas was slow and 201T1 was present even after 96 hours (Fig. 2) , but 201T1 in cere bral metastases after 96 hours was almost washed out (Fig. 3) .
There was no difference in thallium index between fibrous and meningothelial meningiomas. No difference in thallium index was identified among cerebral metastases from different primary origins. We therefore tried to distinguish Histological studies demonstrated an undifferentiated adenocarcinoma.
gliomas from cerebral metastases by superdelayed scanning. Our results showed that the thallium in dices on superdelayed images (96 hrs after injection of 201T1 Cl) of five of six gliomas were higher than 0.4, while those of six of seven cerebral metastases were lower than 0.3. Therefore, superdelayed im aging could distinguish cerebral metastases from gliomas. The mechanism causing the different washout rates of gliomas and cerebral metastases is still unknown. However, as cell growth is correlated with Na+-K+ ATPase activity,""" the slow washout in gliomas may be due to lower activity of Na+-K+ AT Pase compared with metastatic brain tumors.
The 201T1 SPECT findings in our series agreed well with the histological data. In all seven patients with cerebral metastases, early images showed regions of moderate 201T1 uptake and superdelayed images show ed low uptake compared with that of gliomas.
This preliminary study has not determined the limitations of the thallium index for distinguishing cerebral metastases from gliomas on superdelayed im ages. Also, the cerebral metastases originated from only two locations, so other types of metastasis should be investigated.
